These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8655983)
1. Oral immunization of mice against candidiasis. Jensen J; Warner T; Johnson C; Balish E J Infect Dis; 1996 Jul; 174(1):133-40. PubMed ID: 8655983 [TBL] [Abstract][Full Text] [Related]
2. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice. Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574 [TBL] [Abstract][Full Text] [Related]
3. Vaccination with Secreted Aspartyl Proteinase 2 Protein from Shukla M; Rohatgi S Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125 [TBL] [Abstract][Full Text] [Related]
4. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis. Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941 [TBL] [Abstract][Full Text] [Related]
5. Impaired immune response to Candida albicans in aged mice. Murciano C; Villamón E; Yáñez A; O'Connor JE; Gozalbo D; Gil ML J Med Microbiol; 2006 Dec; 55(Pt 12):1649-1656. PubMed ID: 17108267 [TBL] [Abstract][Full Text] [Related]
6. Dual-antigen fusion protein vaccination induces protective immunity against Jia K; Zhang Y; Jiang M; Cui M; Wang J; Zhang J; Wang H; Zhao H; Li M; Zou Q; Zeng H Hum Vaccin Immunother; 2024 Dec; 20(1):2406065. PubMed ID: 39327639 [No Abstract] [Full Text] [Related]
7. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein. Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606 [TBL] [Abstract][Full Text] [Related]
8. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine. Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271 [TBL] [Abstract][Full Text] [Related]
10. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein. Tavares D; Ferreira P; Arala-Chaves M Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195 [TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity. Han Y; Rhew KY Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of fungal extracellular vesicles against murine candidiasis. Vargas G; Honorato L; Guimarães AJ; Rodrigues ML; Reis FCG; Vale AM; Ray A; Nosanchuk JD; Nimrichter L Cell Microbiol; 2020 Oct; 22(10):e13238. PubMed ID: 32558196 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Montagnoli C; Sandini S; Bacci A; Romani L; La Valle R Med Mycol; 2004 Aug; 42(4):319-24. PubMed ID: 15473356 [TBL] [Abstract][Full Text] [Related]
14. Active and passive immunization against oral Candida albicans infection in a murine model. Farah CS; Ashman RB Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599 [TBL] [Abstract][Full Text] [Related]
15. Serum antibody response of gnotobiotic athymic and euthymic mice following alimentary tract colonization and infection with Candida albicans. Balish E; Filutowicz H Can J Microbiol; 1991 Mar; 37(3):204-10. PubMed ID: 2054747 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin. Balish E; Warner TF; Nicholas PJ; Paulling EE; Westwater C; Schofield DA Infect Immun; 2005 Mar; 73(3):1313-20. PubMed ID: 15731028 [TBL] [Abstract][Full Text] [Related]
17. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. Cenci E; Mencacci A; Spaccapelo R; Tonnetti L; Mosci P; Enssle KH; Puccetti P; Romani L; Bistoni F J Infect Dis; 1995 May; 171(5):1279-88. PubMed ID: 7751704 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis. Han Y; Rhew KY Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645 [TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immune responses to enolase after alimentary tract colonization or intravenous immunization with Candida albicans. Sundstrom P; Jensen J; Balish E J Infect Dis; 1994 Aug; 170(2):390-5. PubMed ID: 8035025 [TBL] [Abstract][Full Text] [Related]
20. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus. Cutler JE; Corti M; Lambert P; Ferris M; Xin H PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]